Form Type: 4

SEC EDGAR Link
Accession Number:0001562180-22-004878
Date:2022-06-03
Issuer: REGENXBIO INC. (RGNX)
Original Submission Date:

Reporting Person:

KARABELAS ARGERIS N
C/O REGENXBIO INC.
9804 MEDICAL CENTER DRIVE ROCKVILLE, MD 20850

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2022-06-03 A 3,010 a $0.00 3,010 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 22.84 2022-06-03 deemed execution date A 15,324 (a) 2032-06-03 common stock 15,324 $22.84 15,324 direct
Footnotes
IDfootnote
f1 represents shares of common stock underlying a time-based restricted stock unit award (rsu). 100% of the shares subject to this rsu will vest on june 1, 2023 while the recipient provides continuous service to the issuer.
f2 the option will vest in 12 equal monthly installments following june 3, 2022 while the optionee provides continuous service to the issuer.
WhaleWisdom Logo

Elevate your investments